Ergoteles LLC Medicinova Inc Transaction History

Ergoteles LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.09 - $2.43 $79,677 - $92,638	-38,123 Reduced 55.06%	31,117 $71,000
Q1 2023 May 10, 2023	SELL	$1.95 - $2.54 $81,424 - $106,060	-41,756 Reduced 37.62%	69,240 $149,000
Q4 2022 Feb 14, 2023	BUY	$1.97 - $2.66 $218,662 - $295,249	110,996 New	110,996 $227,000
Q1 2022 May 13, 2022	SELL	$2.19 - $2.81 $22,907 - $29,392	-10,460 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.61 - $4.42 $219,331 - $371,434	-84,035 Reduced 88.93%	10,460 $28,000
Q3 2021 Nov 15, 2021	SELL	$3.4 - $4.24 $281,645 - $351,228	-82,837 Reduced 46.71%	94,495 $358,000
Q2 2021 Aug 12, 2021	BUY	$3.76 - $5.14 $666,768 - $911,486	177,332 New	177,332 $754,000

4.83M

9.4K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $104M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.